Cargando…

Activity of roniciclib in medullary thyroid cancer

Altered cyclin-dependent kinase activity is observed in many human malignancies. Cyclin-dependent kinases that promote cell cycle progression may be promising targets in the treatment of cancer. The therapeutic effects of roniciclib, a cyclin-dependent kinase inhibitor for medullary thyroid cancer w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Shu-Fu, Lin, Jen-Der, Hsueh, Chuen, Chou, Ting-Chao, Wong, Richard J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021325/ https://www.ncbi.nlm.nih.gov/pubmed/29963260 http://dx.doi.org/10.18632/oncotarget.25555

Ejemplares similares

Effects of roniciclib in preclinical models of anaplastic thyroid cancer
por: Lin, Shu-Fu, et al.
Publicado: (2017)

Efficacy of an HSP90 inhibitor, ganetespib, in preclinical thyroid cancer models
por: Lin, Shu-Fu, et al.
Publicado: (2017)

A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer
por: Lin, Shu-Fu, et al.
Publicado: (2017)

Utility of a PI3K/mTOR Inhibitor (NVP-BEZ235) for Thyroid Cancer Therapy
por: Lin, Shu-Fu, et al.
Publicado: (2012)

Soft tissue invasion of papillary thyroid carcinoma
por: Lin, Jen-Der, et al.
Publicado: (2016)

Roniciclib down-regulates stemness and inhibits cell growth by inducing nucleolar stress in neuroblastoma
por: Ognibene, Marzia, et al.
Publicado: (2020)

Utility of a Histone Deacetylase Inhibitor (PXD101) for Thyroid Cancer Treatment
por: Lin, Shu-Fu, et al.
Publicado: (2013)

Prognosis of Multifocal Papillary Thyroid Carcinoma
por: Kuo, Sheng-Fong, et al.
Publicado: (2013)

Prognostic significance and optimal cutoff of age in medullary thyroid cancer
por: Qu, Ning, et al.
Publicado: (2016)

Long-term follow-up of papillary and follicular thyroid carcinomas with bone metastasis
por: Lin, Jen-Der, et al.
Publicado: (2017)

Phase I dose-escalation studies of roniciclib, a pan-cyclin-dependent kinase inhibitor, in advanced malignancies
por: Bahleda, Rastislav, et al.
Publicado: (2017)

Long-Term Follow-Up of the Therapeutic Outcomes for Papillary Thyroid Carcinoma With Distant Metastasis
por: Lin, Jen-Der, et al.
Publicado: (2015)

Medullary Thyroid Cancer: It is a pain in the neck?
por: Guerrero, Marlon A., et al.
Publicado: (2011)

Therapeutic Outcome of Second Primary Malignancies in Patients with Well-Differentiated Thyroid Cancer
por: Liou, Miaw-Jene, et al.
Publicado: (2016)

Gender-Specific Variation in the Prognosis of Papillary Thyroid Cancer TNM Stages II to IV
por: Hsieh, Sheng-Hwu, et al.
Publicado: (2012)

Therapeutic inhibition of polo‐like kinases in anaplastic thyroid cancer
por: Lin, Shu‐Fu, et al.
Publicado: (2021)

Primary lung cancer with radioiodine avidity: A thyroid cancer cohort study
por: Lu, Yu-Ling, et al.
Publicado: (2021)

Diagnosis of medullary thyroid cancer
por: Marchisotta, Stefania, et al.
Publicado: (2009)

Development and validation of prognostic nomograms for medullary thyroid cancer
por: Guan, Yong-jun, et al.
Publicado: (2019)

Putative BRAF activating fusion in a medullary thyroid cancer
por: Kasaian, Katayoon, et al.
Publicado: (2016)

Integrated analysis of fine-needle-aspiration cystic fluid proteome, cancer cell secretome, and public transcriptome datasets for papillary thyroid cancer biomarker discovery
por: Wu, Chia-Chun, et al.
Publicado: (2018)

Disease-Specific Mortality and Secondary Primary Cancer in Well-Differentiated Thyroid Cancer with Type 2 Diabetes Mellitus
por: Chen, Szu-Tah, et al.
Publicado: (2013)

Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis
por: Liu, Feng‐Hsuan, et al.
Publicado: (2015)

Medullary Thyroid Cancer: Updates and Challenges
por: Gild, Matti L, et al.
Publicado: (2023)

Efficacy and Biomarker Analysis of Adavosertib in Differentiated Thyroid Cancer
por: Lu, Yu-Ling, et al.
Publicado: (2021)

Analysis of the lower incidence of medullary thyroid cancer in China
por: Huang, Min, et al.
Publicado: (2019)

Metastatic papillary thyroid cancer to cerebellum with incidental medullary microcarcinoma
por: Wang, Mawson, et al.
Publicado: (2022)

Thyroid: Medullary Carcinoma
por: Somnay, Yash R., et al.
Publicado: (2013)

Genetic and Epigenetic of Medullary Thyroid Cancer
por: Khatami, Fatemeh, et al.
Publicado: (2018)

Treatment of advanced medullary thyroid cancer
por: Smit, Johannes
Publicado: (2013)

An Introduction to Managing Medullary Thyroid Cancer
por: de Groot, Jan Willem, et al.
Publicado: (2006)

A Benign Medullary Thyroid Cancer
por: Pishdad, Reza, et al.
Publicado: (2022)

RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases
por: Romei, Cristina, et al.
Publicado: (2018)

Nationwide cohort study on the epidemiology and survival outcomes of thyroid cancer
por: Liu, Fu-Chao, et al.
Publicado: (2017)

International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma
por: Xu, Bin, et al.
Publicado: (2022)

Shear wave elastography in medullary thyroid carcinoma diagnostics
por: Dobruch-Sobczak, Katarzyna, et al.
Publicado: (2015)

The Genetic Aspects of Medullary Thyroid Carcinoma: Recognition and Management
por: Williamson, Paula, et al.
Publicado: (1996)

Targeted Treatment of Differentiated and Medullary Thyroid Cancer
por: Bales, Shannon R., et al.
Publicado: (2011)

Update on Targeted Therapy in Medullary Thyroid Cancer
por: Okafor, Christian, et al.
Publicado: (2021)

Noncoding RNA blockade of autophagy is therapeutic in medullary thyroid cancer
por: Gundara, Justin S, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mnlk5hnkj9pnif4gsgfklai4cb